Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Alonso

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 1, 2014
Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical testsAntoni Castells, Enrique Quintero, Cristina Álvarez, et al.
Inflammatory Bowel Diseases|March 22, 2024
The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCUIria Bastón-Rey, Iago Rodríguez-Lago, Ana María Luque, et al.
Journal of Crohn'S & Colitis|November 6, 2023
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA RegistryDiego Casas Deza, Cristina Polo Cuadro, Ruth de Francisco, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2026
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA RegistryManuel Barreiro-de Acosta, Yamile Zabana, Laura Nieto-García, et al.
Gut|January 11, 2025
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCUJavier P Gisbert, María G Donday, Sabino Riestra, et al.
Journal of Clinical Medicine|January 10, 2026
Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced ColitisDiego Casas Deza, Cristina Polo Cuadro, Marta Gascón Ruiz, et al.
Gastroenterologia Y Hepatologia|May 6, 2024
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohortCristina Suárez Ferrer, Francisco Mesonero Gismero, Berta Caballol, et al.
Journal of Clinical Medicine|July 2, 2021
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological StudyMaría Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Journal of Clinical Medicine|October 14, 2022
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. <i>J. Clin. Med.</i> 2021, <i>10</i>, 2885María Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 1, 2014
Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical testsAntoni Castells, Enrique Quintero, Cristina Álvarez, et al.
Inflammatory Bowel Diseases|March 22, 2024
The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCUIria Bastón-Rey, Iago Rodríguez-Lago, Ana María Luque, et al.
Journal of Crohn'S & Colitis|November 6, 2023
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA RegistryDiego Casas Deza, Cristina Polo Cuadro, Ruth de Francisco, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2026
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA RegistryManuel Barreiro-de Acosta, Yamile Zabana, Laura Nieto-García, et al.
Gut|January 11, 2025
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCUJavier P Gisbert, María G Donday, Sabino Riestra, et al.
Journal of Clinical Medicine|January 10, 2026
Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced ColitisDiego Casas Deza, Cristina Polo Cuadro, Marta Gascón Ruiz, et al.
Gastroenterologia Y Hepatologia|May 6, 2024
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohortCristina Suárez Ferrer, Francisco Mesonero Gismero, Berta Caballol, et al.
Journal of Clinical Medicine|July 2, 2021
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological StudyMaría Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Journal of Clinical Medicine|October 14, 2022
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. <i>J. Clin. Med.</i> 2021, <i>10</i>, 2885María Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Pageof 7